Publikace
- Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo2016 | 1. lékařská fakulta
- Detailed Functional and Proteomic Characterization of Fludarabine Resistance in Mantle Cell Lymphoma Cells2015 | 1. lékařská fakulta
- Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents2014 | 1. lékařská fakulta
- Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic2023 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové, 3. lékařská fakulta
- mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma2023 | 1. lékařská fakulta, 3. lékařská fakulta
- Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy2023 | 1. lékařská fakulta, 2. lékařská fakulta
- Cell-specific modulation of mitochondrial respiration and metabolism by the pro-apoptotic Bcl-2 family members Bax and Bak2023 | 1. lékařská fakulta, Přírodovědecká fakulta
- Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping2023 | 1. lékařská fakulta
- Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma2023 | 1. lékařská fakulta
- BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis2023 | 1. lékařská fakulta
Loading network view...